NIAID describes research priorities for fighting drug-resistant tuberculosis.
D000995:Antitubercular Agents / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000517:prevention & control*; D014943:Global Health; D006292:Health Priorities / Q000458:organization & administration*; D006801:Humans; D054579:National Institute of Allergy and Infectious Diseases (U.S.) / Q000458:organization & administration; D012107:Research Design; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology* / Q000517:prevention & control*; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology* / Q000517:prevention & control*; D014481:United States; D014944:World Health Organization
D000995:Antitubercular Agents